Avenue Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Avenue Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Highlights
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Avenue Therapeutics | DEFA14A: Others
Avenue Therapeutics | DEF 14A: Definitive information statements
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | DEF 14C: Definitive information statements
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | DEF 14C: Definitive information statements
Avenue Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Avenue Therapeutics | 8-K: Current report
Avenue Therapeutics | 8-K: Current report
No Data